Combined exposure to THC, CBD, and nicotine in human fetal lung explants (10–16 weeks gestation) suppresses Ki-67-marked proliferation, disrupts smooth muscle cell differentiation, and drives a senescence-like state confirmed by elevated CDKN1A and CDKN2A expression, collapsed LAMIN B1 architecture, and activated DNA damage markers γH2A.X and 53BP1. The combination also triggers interferon pathway upregulation (MX1, IFI2) and a broad SASP cytokine signature including IL-6, IL-8, TNFα, and TSLP — all partially reversed by the senolytic pair Dasatinib and Quercetin.
This finding carries significant weight because it uses primary human fetal tissue rather than animal models, placing it closer to clinical relevance than most prenatal toxicology research. The senescence mechanism is particularly alarming: premature cellular aging in second-trimester lung progenitors could permanently reduce alveolar cell pools, potentially explaining the elevated asthma and pulmonary dysfunction rates observed in children of cannabis-using mothers in epidemiological cohorts. The interferon pathway activation is a less-anticipated finding, suggesting an innate immune-like stress response layered atop structural damage.
The senolytic rescue data are intriguing but carry an obvious limitation — Dasatinib is a tyrosine kinase inhibitor with substantial toxicity, making it an unrealistic prenatal intervention. Quercetin alone warrants isolated investigation. The explant model also lacks vascular and immune cell crosstalk present in vivo. Overall, this is a mechanistically rich, incrementally paradigm-shifting study that reframes prenatal cannabis exposure as a driver of accelerated fetal lung aging.